Early Feasibility of 'Pivot Extend' for Tricuspid Regurgitation Treatment

NARecruitingINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

December 31, 2026

Conditions
Tricuspid Regurgitation (TR)
Interventions
DEVICE

Pivot Extend Tricuspid Regurgitation Spacer Device

The Pivot Extend Tricuspid Regurgitation Spacer Device is an investigational implant designed to reduce tricuspid regurgitation (TR) by occupying the regurgitant orifice and improving leaflet coaptation. The device is implanted via a transcatheter procedure under imaging guidance. Following implantation, participants will undergo post-procedural monitoring for at least 24 hours to ensure safety and device stability. The device is intended for long-term placement, with scheduled follow-up assessments at designated intervals over a 12-month period to evaluate its safety and efficacy. Device removal may be performed if adverse events occur or if deemed necessary by the investigator.

Trial Locations (3)

0102

RECRUITING

Israeli-Georgian Medical Research Clinic Healthycore, Tbilisi

0159

RECRUITING

Tbilisi Heart and Vascular Clinic, Tbilisi

0186

RECRUITING

Tbilisi Heart Center, Tbilisi

All Listed Sponsors
lead

Tau-MEDICAL Co., Ltd.

INDUSTRY

NCT06877520 - Early Feasibility of 'Pivot Extend' for Tricuspid Regurgitation Treatment | Biotech Hunter | Biotech Hunter